MyPillow CEO Mike Lindell joins Yahoo Finance’s Zack Guzman to discuss his appearance at the White House press conference Monday and how his pillow company is helping combat the coronavirus outbreak.
MyPillow CEO Mike Lindell joins Yahoo Finance’s Zack Guzman to discuss his appearance at the White House press conference Monday and how his pillow company is helping combat the coronavirus outbreak.
A ranking House Republican is formally asking the Justice Department to broaden its investigation to include President Trump’s conduct during the Jan. 6 attack on the U.S. Capitol.
As a precaution against coordinated violence as the US approaches President-elect Joe Biden's inauguration, Facebook announced a few new measures it's putting in place. In a blog post and tweets from Facebook Policy Communications Director Andy Stone, the company explained that it would block any events slated to happen near the White House, the U.S. Capitol or any state capitol building through Wednesday. At this point, that includes any content connected to the "Stop the Steal" movement perpetuating the rampant lie that Biden's victory is illegitimate.
Donald Trump’s acting Pentagon chief says he “cannot wait” to leave his job in less than a week. Acting Secretary of Defence Christopher Miller made the surprising comments to press as he returned from a trip back from Nebraska, Tennessee and Colorado. Mr Miller, who has only been in the job for two months, made the comments when he was asked about the F-35 Joint Strike Fighter, the most expensive weapons system in history.
Hyderabad (Telangana) [India], January 16 (ANI): Urging governments of Andhra Pradesh and Telangana to act against illegal mining in their states, Nizamabad BJP Member of Parliament (MP) Dharmapuri Arvind said that My Home Industries Private Limited (MHIPL) should not be allocated more land for mining in both the states.
The share who say they approve of the siege has fallen since last week, a HuffPost/YouGov survey finds.
The latest news on COVID-19 developments in Canada (all times Eastern): 7:20 p.m. Alberta's health minister says it will take longer than expected to start immunizing seniors over 75 outside long-term care homes due to a delay in manufacturing one of the COVID-19 vaccines. Tyler Shandro says the news out of Ottawa is a blow and it's not clear how the delay will affect Alberta's vaccine allocation in the coming weeks. He says the government had hoped to announce in the coming days that seniors over 75 and Indigenous people over 65 would be eligible to get their shots, but now the timeline is in question. Senior medical officer of health Dr. Laura McDougall says Alberta is still ramping up its ability to administer vaccines as quickly as possible. --- 6:30 p.m. British Columbia health officials say they are disappointed to hear there will be a short-term delay in the delivery of the Pfizer-BioNTech vaccine. Their comments came as the province reported 509 new COVID-19 cases for a total of 60,117 infections in British Columbia. It also reported an additional nine deaths, bringing the total number of fatalities to 1,047. The number of people who have recovered stands at 53,115. The number of British Columbians who have received their first dose of a COVID-19 vaccine so far is 75,914. --- 5:40 p.m. Alberta is reporting 785 new cases of COVID-19. It says there have also been an additional 13 deaths. There are 796 people in hospital, and 124 of those are in intensive care. There are 12,189 active infections. --- 5:10 p.m. A person in Yellowknife has tested positive for COVID-19. Chief public health officer Dr. Kami Kandola says the person has not travelled and there is no known source of infection at this time. Currently, there are no other active cases of COVID-19 in Yellowknife. Kandola says the new case was locally acquired but the source is unknown. A rapid response team has been deployed to investigate the source of the new case. --- 3:35 p.m. Newfoundland and Labrador is reporting one new case of COVID-19 today. The new case involves a woman between 20 and 39 years old in the eastern health region. Officials say the woman is a resident of the province who travelled internationally. Newfoundland and Labrador has five active reported cases and one person is in hospital with the disease. --- 2:55 p.m. Health officials in Saskatchewan are announcing another 382 cases of COVID-19. Four more residents who were 60 and older have also died. There are 210 people in hospital, with 35 people in intensive care. To date, 14,017 vaccine doses have gone into the arms of the province's elderly and health-care workers. Saskatchewan's chief medical health officer warned that next week, he will recommend the Saskatchewan Party government tighten up its public-health orders if the province continues to see 300 or more new cases daily. --- 2 p.m. The Manitoba government is seeking public input on a potential easing of COVID-19 restrictions on business openings and public gatherings. Dr. Brent Roussin, the province's chief public health officer, says daily case numbers have been dropping and the strain on hospitals has been easing. The government has put up an online survey that asks people what they would like to see changed, and a final decision is expected late next week. --- 1:35 p.m. Manitoba is reporting 191 new COVID-19 cases today and five additional deaths. The new cases continue to be especially pronounced in the northern health region. --- 1 p.m. Police in Ottawa say they have charged a 62-year-old man from California for violating the quarantine rules meant to reduce the spread of COVID-19. In a statement, they say the man arrived in Canada Jan. 6 and was required to stay isolated until Jan. 19, but was visited "on several occasions and for extended periods of time" by an Ottawa resident. They don't name the man or say what his relationship is to his visitor, but say he came from California, a state struggling more than most with the novel coronavirus. The section of the Quarantine Act that forbids visits to people in quarantine carries a potential maximum punishment of six months in jail and a $750,000 fine. The police statement says the visitor was let off with a warning. --- 12:42 New Brunswick is reporting 25 new cases of COVID-19 today across almost all of its health zones. Health officials say the new cases are under investigation and the Miramichi area is the only region without active reported infections. The province says it has 256 active cases and four people are in hospital with the disease. New Brunswick remains at the second-highest pandemic alert level. --- 11:55 Prime Minister Justin Trudeau says a temporary delay in deliveries of the Pfizer-BioNTech vaccine will not derail efforts to vaccinate Canadians by September. Trudeau says Pfizer's production issues will not affect plans to have enough vaccines available for every Canadian who wants one by the fall. He says "it's only expected that there will be a few bumps along the way." Pfizer Canada says modifications at its Belgium facility will affect deliveries for all countries it supplies. --- 10:57 Nova Scotia is reporting two new cases of COVID-19 today. Officials say one case was identified in the northern zone and one in the central zone, which includes Halifax. They say both cases involve close contacts of previously reported infections. Nova Scotia has 32 active reported cases of the disease. --- 10:30 a.m. Ontario is reporting 100 deaths linked to COVID-19 today after a data entry error in one of its public health units. Forty-six deaths from Middlesex-London were added to the province's daily count that actually happened earlier in the pandemic. The province is also reporting 2,998 new cases of COVID-19. Health Minister Christine Elliott says 800 of those new cases are in Toronto, 618 in Peel Region and 250 in York Region. --- 9:56 a.m. Chief Public Health Officer Dr. Theresa Tam says Canada is on track to hit 10,000 new daily infections of COVID-19 by the end of January. New modelling shows the total number of cases could reach 796,630 by Jan. 24 and another 2,000 people could die. Tam says there is rapid and widespread community spread of COVID-19, and governments and individuals need to do everything they can to reduce contacts. She says measures to reduce contacts must be kept in place long enough to prevent an immediate resurgence of infections as soon as the lockdown measures are lifted. --- 9:40 a.m. U.S. drug-maker Pfizer is temporarily cutting back vaccine deliveries to Canada because of issues with its European production lines. Procurement Minister Anita Anand says Pfizer thinks it will still be able to deliver four million doses by the end of March, but it's no longer guaranteed. Canada has received about 380,000 doses of the vaccine so far, and was supposed to get another 400,000 this month, followed by almost two million doses in February. There is no update yet on what the new deliveries will be. --- This report by The Canadian Press was first published Jan. 15, 2021. The Canadian Press
Contamination ‘probably a one-off’ and no cause for panic, virologist says
The five best things we heard this week.
PLANO, Texas, Jan. 15, 2021 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE:ITGR) announced today that it plans to release financial and operational results for fourth quarter and full-year 2020, at 8 a.m. Eastern Time (ET) on Thursday, February 18, 2021. Following the release, Integer management will host a webcast at 9 a.m. ET to discuss these results. Other forward-looking and material information may also be discussed during this call. Conference call details: Date: Thursday, February 18, 2021Time: 9 a.m. ET / 8 a.m. CTDomestic dial-in number: 1-833-714-0898International dial-in number: +1 778-560-2691Conference ID: 1898248Webcast Registration: ITGR Q4 2020 Earnings Call An audio replay will be available for 7 days and can be accessed by dialing 800-585-8367 or 416-621-4642 and using Conference ID 1898248. The conference call will also be available live or archived replay on the Investor Relations section of the Integer website at: investor.integer.net. From time to time, the Company posts information that may be of interest to investors on its website at investor.integer.net. To automatically receive Integer financial news by email, please visit investor.integer.net and subscribe to email alerts. About Integer®Integer Holdings Corporation (NYSE:ITGR) is one of the largest medical device outsource (MDO) manufacturers in the world serving the cardiac, neuromodulation, vascular, portable medical and orthopedics markets. The company provides innovative, high-quality medical technologies that enhance the lives of patients worldwide. In addition, the Company develops batteries for high-end niche applications in energy, military, and environmental markets. The Company's brands include Greatbatch Medical®, Lake Region Medical™ and Electrochem™. Additional information is available at www.integer.net. Investor Relations:Media Relations:Tony BorowiczKelly Butlertony.email@example.com@integer.net716.759.5809214.618.4216
“After all that he has done for our country, you would turn your back and betray him so quickly?” Franklin Graham wrote, saying Trump wasn't "a perfect person."
NEW YORK — The 161 remaining free agents (q-rejected qualifying offer): AMERICAN LEAGUE BALTIMORE (2) —Bryan Holaday, c; Wade LeBlanc, lhp. BOSTON (4) — Jackie Bradley Jr., of; Rusney Castillo, of; Collin McHugh, rhp; Martin Pérez, lhp. CHICAGO (4) — Alex Colomé, rhp; Jarrod Dyson, of; Edwin Encarnación, dh; Gio González, lhp. CLEVELAND (4) — Brad Hand, lhp; César Hernández, 2b; Sandy León, c; Oliver Pérez, lhp. DETROIT (5) — C.J. Cron, 1b; Iván Nova, rhp; Austin Romine, c; Jonathan Schoop, 2b; Jordan Zimmermann, rhp. HOUSTON (4) — Michael Brantley, of; Brad Peacock, rhp; Josh Reddick, of; q-George Springer, of. KANSAS CITY (3) — Alex Gordon, of; Matt Harvey, rhp; Ian Kennedy, rhp. LOS ANGELES (2) — Andrelton Simmons, ss; Julio Teheran, rhp. MINNESOTA (8) — Ehire Adrianza, inf; Alex Avila, c; Tyler Clippard, rhp; Nelson Cruz, dh; Marwin González, inf; Rich Hill, lhp; Jake Odorizzi, rhp; Sergio Romo, rhp. NEW YORK (6)— Brett Gardner, of; JA Happ, lhp; Erik Kratz, c; q-DJ LeMahieu, 2b; James Paxton, lhp; Masahiro Tanaka, rhp. OAKLAND (7) — Mike Fiers, rhp; Tommy La Stella, 2b; Jake Lamb, 3b; T.J. McFarland, lhp; Yusmeiro Petit, rhp; Marcus Semien, ss; Joakim Soria, rhp. SEATTLE (3) — Dee Gordon, 2b; Kendall Graveman, rhp; Yoshihisa Hirano, rhp. TAMPA BAY (1) — Aaron Loup, lhp. TEXAS (8) — Jesse Chavez, rhp; Shin-Soo Choo, of-dh; Derek Dietrich, inf; Corey Kluber, rhp; Jeff Mathis, c; Juan Nicasio, rhp; Andrew Romine, inf; Edinson Vólquez, rhp. TORONTO (7) — Chase Anderson, rhp; Anthony Bass, rhp; Ken Giles, rhp; Joe Panik, 2b; Matt Shoemaker, rhp; Jonathan Villar, ss-2b; Taijuan Walker, rhp. ___ NATIONAL LEAGUE ARIZONA (4) — Jon Jay; of; Mike Leake, rhp; Héctor Rondón, rhp; Yasmany Tomás, of-3b. ATLANTA (9) — Tyler Flowers, c; Shane Greene, rhp; Cole Hamels, lhp; Adeiny Hechavarría, ss; Nick Markakis, of; Mark Melancon, rhp; Darren O'Day, rhp; Marcell Ozuna, of; Pabo Sandoval, 3b. CHICAGO (10) — Andrew Chafin, lhp; Tyler Chatwood, rhp; Daniel Descalsco, 2b; Billy Hamilton, of; Jeremy Jeffress, rhp; Jason Kipnis, 2b; Jon Lester, lhp; Cameron Maybin, of; Josh Phegley, c; José Quintana, lhp. CINCINNATI (3) — q-Trevor Bauer, rhp; Freddy Galvis, ss; Tyler Thornburg, rhp. COLORADO (6) — Drew Butera, Matt Kemp, of; Daniel Murphy, 1b; Chris Owings ss-2b-of; Kevin Pillar, of; A.J. Ramos, rhp. LOS ANGELES (5) — Kiké Hernández, of-inf; Jake McGee, lhp; Jimmy Nelson, rhp; Joc Pederson, of; Justin Turner, 3b. MIAMI (7) — Brad Boxberger, rhp; Francisco Cervelli, c; Logan Forsythe, inf; Brandon Kintzler, rhp; Matt Joyce, of; Sean Rodríguez, 3b; Nick Vincent, rhp. MILWAUKEE (4) — Brett Anderson, lhp; Ryan Braun, of; Jedd Gyorko, 3b; Eric Sogard, 2b. NEW YORK (12) — Yoenis Céspedes, of; Robinson Chirinos, c; Todd Frazier, 3b; Jared Hughes, rhp; Jed Lowrie, 2b-3b; Jake Marisnick, of; Eduardo Núñez, 2b; Rick Porcello, rhp; Erasmo Ramírez, rhp; Wilson Ramos, c; René Rivera, c; Justin Wilson, lhp. PHILADELPHIA (9) — José Álvarado, lhp; p-Jake Arrieta, rhp; Jay Bruce, of; Didi Gregorius, ss; Tommy Hunter, rhp; David Phelps, rhp; q-J.T. Realmuto, c; David Robertson, rhp; Brandon Workman, rhp. PITTSBURGH (3) — Chris Archer, rhp; Derek Holland, lhp; Keone Kela, rhp. ST. LOUIS (5) — Brad Miller, 3b; Yadier Molina, c; Adam Wainwright, rhp; Matt Wieters, c; Kolten Wong, 2b. SAN DIEGO (6) — Jason Castro, c; Mitch Moreland, 1b; Jurickson Profar, 2b; Garrett Richards, rhp; Trevor Rosenthal, rhp; Kirby Yates, rhp. SAN FRANCISCO (2) — Trevor Cahill, rhp; Tony Watson, lhp. WASHINGTON (8) — Asdrúbal Cabrera, 3b; Sean Doolittle, lhp; Brock Holt, inf-of; Howie Kendrick,1b-inf; Aníbal Sánchez, rhp;Kurt Suzuki, c; Eric Thames, 1b; Ryan Zimmerman, 1b. The Associated Press
The nature of the investigation into the linebacker has not been released and no charges have been filed against him
The Houston Astros agreed to oneyear contracts with righthander Lance McCullers Jr. and infielder Aledmys Daz on Friday to avoid salary arbitration.
Stewart Cink could not remember a more ideal day in Hawaii, and he had a round that matched the occasion. Enjoying a surge in the twilight of his career, the 47-year-old Cink putted for birdie on all but one hole Friday on his way to a 7-under 63 that gave him a share of the early lead with Webb Simpson. Cink already won the season-opener in the Safeway Open in September, his first victory since the 2009 British Open at Turnberry.
Fiat Chrysler and PSA will seal their long-awaited merger on Saturday to create Stellantis, the world's fourth-largest auto group with deep enough pockets to fund the shift to electric driving and take on bigger rivals Toyota and Volkswagen. It took over a year for the Italian-American and French automakers to finalise the $52 billion deal, during which the global economy was upended by the COVID-19 pandemic. Shares in Stellantis, which will be headed by current PSA Chief Executive Carlos Tavares, will start trading in Milan and Paris on Monday, and in New York on Tuesday.
OTTAWA — Only half of Canada's promised COVID-19 vaccine doses by Pfizer-BioNTech will arrive in the next month, federal officials revealed Friday, blaming production issues in Belgium that will affect immediate vaccination plans. Procurement Minister Anita Anand said Canada faces an "unfortunate" delay that is nonetheless expected to be made up by the end of March, while Prime Minister Justin Trudeau insisted most Canadians will still be vaccinated by the fall. News of the Pfizer delay drew immediate concern from Saskatchewan Premier Scott Moe, who said the province's strategy for the two-dose regime depends on steady shipments. "We have been planning our vaccine rollout based on this schedule, including second dosages," said Moe, noting he expected 11,700 doses a week in February. "If this has changed, they need to advise us immediately." In British Columbia, where all available doses are being deployed as they arrive, Health Minister Adrian Dix said the delay will have "some significant effect" on when priority groups get their shot. "Obviously, when you receive fewer doses you immunize fewer people," said Dix. The delay could also affect the wait time between each shot of the two-dose regime, he said. Although Pfizer-BioNTech suggests a second dose 21 days after the first, provincial health officer Dr. Bonnie Henry has said that could be extended to 35 days. A spokeswoman for Quebec Health Minister Christian Dube said the temporary slowdown reinforced the province's decision to wait up to 90 days to administer the vaccine's second dose. "The strategy remains the same: we must give a boost now and vaccinate as many vulnerable people and health workers as possible, as quickly as possible," said Marjaurie Cote-Boileau. Alberta decided earlier this week to push back its second shots to 42 days. The province's health minister, Tyler Shandro, said Friday he had hoped to soon announce all seniors over 75 and Indigenous people over 65 would be eligible for the vaccine, but the delay makes that out of the question. Ontario Premier Doug Ford said the province was evaluating the impact of the delay and "will adjust as necessary." Maj.-Gen. Dany Fortin, who is leading the national vaccine distribution, said Pfizer's production delays would reduce deliveries by an average of 50 per cent over the coming weeks. He said that won't be felt until after next week because Canada's upcoming shipment has already been prepared. But the final week of January will bring "about a quarter of what we expected." "The numbers will pick right back up after that to about half of what we had expected (and) progressively grow into the rest of February," said Fortin. "Pfizer is telling us it will impact us for four weeks." According to the government's website, more than 200,000 doses of the Pfizer-BioNTech COVID-19 vaccine were expected in each of the next two weeks and 1.4 million doses were expected in February. Trudeau said Ottawa was "working day in and day out to get vaccines delivered as quickly as possible" but acknowledged that Pfizer-BioNTech doses have been derailed in the short-term. Trudeau said this is why Canada has one of the most diverse vaccine portfolios in the world, pointing to seven bilateral agreements he says ensure "flexibility when it comes to supply chains." "I want to be very clear: this does not impact our goal to have enough vaccines available by September for every Canadian who wants one," Trudeau said from outside Rideau Cottage. Anand said all countries that receive vaccines from Pfizer's European facility have been affected but that Canada has been assured it will receive four million doses by the end of March. "This is unfortunate. However such delays and issues are to be expected when global supply chains are stretched well beyond their limits," Anand said at a news conference. "It's not a stoppage." Pfizer Canada spokeswoman Christina Antoniou said the production facility in Puurs, Belgium, is undergoing modifications in the coming weeks to increase the number of doses it can pump out. Pfizer hopes to double its 2021 production to two billion doses. “Pfizer Canada will continue to pursue its efforts in anticipation that by the end of March, we will be able to catch up to be on track for the total committed doses for Q1,” Antoniou said. The news came as Ottawa released federal projections that suggested the pandemic may soon exceed levels seen in the first wave, rising to 19,630 cumulative deaths and 10,000 daily infections in a little over a week. The modelling shows total cases could grow to nearly 796,630 from about 694,000, and that another 2,000 people could die by Jan. 24. Chief public health officer Dr. Theresa Tam urged sustained vigilance as a long-range forecast suggested rapid growth would continue without "quick, strong and sustained" measures. Tam said that's especially so in national hot spots of Quebec and Ontario, where a steady increase in hospitalizations has strained the health system's ability to keep up with critical care demands. The post-holiday projections do not take into account Quebec's recently implemented four-week curfew or Ontario's new stay-at-home orders. Tam emphasized the need to reduce community spread to help relieve some of the pressure on hospitals and long-term care homes. "The vaccine alone is not going to make a dent in some of that," she said. Ontario reported 100 deaths linked to COVID-19, although that took into account a difference in database reporting between one of its health units and the province. The province's newly resolved tally added 46 deaths from Middlesex-London that occurred earlier in the pandemic. Ontario also reported 2,998 new cases of COVID-19 with 800 of those new cases in Toronto, 618 in Peel Region and 250 in York Region. Quebec reported 1,918 new COVID-19 cases and 62 more deaths, including nine that occurred in the past 24 hours. Concern also remained in Atlantic Canada's hot spot of New Brunswick, which reported 25 new cases and remains at the province's second-highest pandemic alert level. Saskatchewan, with the highest rate of active cases in the country with 329 per 100,000 people, reported another 382 infections and four deaths. — By Cassandra Szklarski in Toronto with files from Catherine Levesque and Mia Rabson in Ottawa, Shawn Jeffords in Toronto, Stephanie Taylor in Regina, and Hina Alam in Vancouver. This report by The Canadian Press was first published Jan. 15, 2021. The Canadian Press Note to readers: This is a corrected story. A previous version misstated the number of Pfizer-BioNTech doses expected in February. It is 1.4 million doses.
The CBC was forced to defend its plans for branded content on its digital platforms Friday as the CRTC peppered senior executives of the public broadcaster with questions about the controversial decision at a broadcast licensing hearing Friday. CBC's new marketing division called Tandem, which creates branded campaign content for corporate clients, has sparked criticism, including denunciations, an open letter and a petition from a number of stakeholders, including former and current CBC journalists. They worry that the paid content blurs the lines between advertising and news and will erode the integrity of CBC journalism. In November more than 70 former CBC employees sent a letter to Canada's broadcast regulator asking it to investigate Tandem. The CRTC is currently holding hearings into CBC's application to renew its various broadcast licences for its English and French services. During Friday's hearings, CRTC Quebec commissioner Alicia Barin asked the corporation how the Tandem initiative aligns with the broadcaster's public service programming mandate to not be unduly influenced by the brands with which it partners. "The concerns that have been expressed very publicly are about the risk of CBC's journalistic reputation being compromised by even participating in branded content," Barin said. "So can you please respond to those concerns?" CBC President Catherine Tait told the commissioners that the network shares those concerns, but said that the Tandem initiative has nothing to do with the underlying journalism and other content that the broadcaster produces. 'Guardrails' in place Tait said she believes much of those concerns were expressed prior to the CBC putting what she called "guardrails" in place that she said would ensure there is no confusion between CBC journalism and commercial advertising. "Now that we have very, very clear guidelines that are going well beyond anybody in the industry, let's see how it goes and let's monitor it," Tait said. Some of those guidelines, which were introduced after concerns were raised about Tandem, include: Restricting branded content to digital platforms Ensuring no CBC/Radio-Canada journalists or hosts will be involved in the creation of branded content. Ensuring branded content will not appear on national news digital pages. The CBC has stressed that initiatives like Tandem are needed to generate revenue amid big financial pressures. Still, Barin pressed the CBC on how the Tandem initiative complies with one of the principles of the broadcaster's Journalistic Standards and Practices, which states it cannot commercially exploit the brand of the corporation's information programming. Users are sophisticated, executive says Barbara Williams, CBC's executive vice-president of English services, said the CBC has to make it very clear that the content is advertising "so that you are not commercially exploiting the content, you are selling the advertising, and you must be very clear about the two." "We do understand that viewers and users and listeners are sophisticated. They have seen this kind of content across many, many organizations," Williams said. "When we make it clear, they understand the difference and they're not confused. And therefore we have not exploited commercially the content." Tait also explained that the CBC has been using branded content since 2016-17. Barin asked why she believed it hadn't been noticed before or made an issue in the past. Tait said she believed that the launch of the name Tandem and "possibly some particular campaigns that caused concern among some of our own employees" were what provoked the response. On Thursday, the CBC is defending its efforts to diversify its workforce and re-think its overall approach to covering news and current affairs to make it more inclusive. The CRTC consultations on CBC licensing will continue through January. The CRTC will hear from individuals, industry and advocacy groups. The CBC will have an opportunity to reply to those submissions on the final day of hearings.
If you believe that franchise fatigue is destroying capital-C Cinema, there’s little to look forward to. But WandaVision shows not all hope is lost
Federal health officials warned Friday that a far more contagious variant of the coronavirus first identified in Britain could become the dominant source of infection in the United States by March, and would likely lead to a wrenching surge in cases and deaths that would further burden overwhelmed hospitals. This dire forecast from the Centers for Disease Control and Prevention made plain what has been suspected for weeks now: The nation is in an urgent race to vaccinate as many Americans as possible before the variant spreads across the country. Public health officials emphasized that protective measures already in place should work against the new variant, and urged Americans to redouble their vigilance in wearing face masks, in maintaining physical distance outside their households, washing hands frequently and limiting social interactions and indoor gatherings. Sign up for The Morning newsletter from the New York Times The variant is not known to be more deadly or to cause more severe disease. But the worrisome warning — hedged by limited data about just how prevalent the variant has become — landed at the end of a week when the nation’s nascent vaccination campaign appeared to be scattershot and still disappointingly elusive for most Americans. It was hampered by confusion over eligibility for people beyond front-line health workers, miscommunication over increasingly limited supplies as demand grew and by bungled rollouts from state to state. The images of elderly Americans standing or sitting for hours in long lines, anxious for their shots while some were turned away, became emblematic of a patchwork approach that belied the promises of protection for the most vulnerable. The CDC’s projections could also prove extremely troubling for hospitals and nursing homes, many of which are already operating at or near capacity. Medical centers and nursing homes have faced increasing rates of infection among their staffs, causing shortages and leading to increased patient loads that have at times jeopardized patient care. “I want to stress that we are deeply concerned that this strain is more transmissible and can accelerate outbreaks in the U.S. in the coming weeks,” said Dr. Jay Butler, deputy director for infectious diseases at the CDC. “We’re sounding the alarm and urging people to realize the pandemic is not over and in no way is it time to throw in the towel.” “We know what works and we know what to do,” he said. The agency’s study lends urgency to the plan announced by President-elect Joe Biden, who is proposing to spend more than than $400 billion to combat the pandemic and accelerate vaccine distribution. It is part of his larger $1.9 trillion economic package aimed at offering financial aid and relief to local governments facing shortfalls and to individuals, and businesses that sustained losses during the nearly yearlong crisis. “The more people we vaccinate and the faster we do it, the sooner we can put this pandemic behind us and the sooner we can build our economy back better and get back to our lives and our loved ones,” Biden said Friday as he announced a five-point vaccination plan. Privately, one CDC official said the prospect of the new variant’s prowess was “chilling,” and underscored the urgent need for people to follow precautions. A bulletin released by the agency — which used highway emergency sign imagery to warn of rising cases, strained hospitals and new more contagious variants — conveyed the sense of urgency. “More spread, more cases, more deaths,” it warned. COVID cases and deaths have broken record after record across the country, with a peak number of deaths, 4,400, announced Tuesday. At least 3,973 new deaths and 238,390 new cases were reported Thursday, and the nation is nearing a milestone of 400,000 deaths. One in 860 Americans have died of COVID in the last year, according to new figures released by the CDC. But the burden of deaths has not fallen equally across racial, ethnic lines and geographic regions, and there is concern that vaccines will not reach the hardest hit communities, where access to health services is limited and distrust is rampant. The new variant could further exacerbate health disparities among communities of color, some experts warned. “I see the new strain as a threat multiplied. Take everything we know about the risk of this virus and just multiply it substantially,” said Dr. Ashish K. Jha, dean of Brown University’s School of Public Health. He expressed concern that the vaccines were not reaching vulnerable communities and called for locating immunization sites in communities of color and using public health messages to alleviate vaccine hesitancy. He also proposed vaccinating all people over the age of 55 after health care workers and those in long-term care facilities are inoculated. The new variant, called B.1.1.7, was first identified in Britain, where it rapidly became the primary source of infections, accounting for more than 80% of new cases diagnosed in London and at least a quarter of cases elsewhere in the country. It has since been detected in at least 50 countries, including the United States and Canada, according to the World Health Organization. In the United States, it accounts for less than 0.5% of cases, based on analysis of a limited number of samples. Other variants circulating in South Africa and Brazil are also considered more contagious, but have not yet been identified in the United States. Japanese authorities said this month that they had detected one of the variants in four passengers arriving from Brazil. The CDC had announced earlier that starting Jan. 26, all airline passengers arriving in the United States, regardless of vaccination status, would be required to show proof of a negative result from a test for the coronavirus or of recovery from COVID. In Britain, infections also spiked in children of all ages, fueling fears that the new variant would be just as dangerous in children as in adults, and forcing Prime Minister Boris Johnson to shut down all schools. But while the new variant is more contagious than previous iterations of the virus, children are still only about half as likely as adults to spread it to others, experts have said. In the new report, CDC scientists devised a model to assess how quickly the variant might spread in the United States, assuming about 10% to 30% of people have preexisting immunity to the virus, and another 1 million people a day will be vaccinated beginning this month. If the variant were about 50% more contagious, as suggested by data from Britain, it would become the predominant source of all infections in the United States by March, the model showed. A slow rollout of vaccinations would hasten that fate. “We know that that’s an overestimate of the current level of vaccination that’s occurring,” said Michael Johansson, a researcher at the CDC. “But certainly, we hope that we get to levels that are higher than that by the time that this period ends.” All viruses accumulate mutations over time; most of the mutations disappear, but those that confer an advantage — greater contagiousness, for example, or faster replication — may take root and spread. A more transmissible variant, in particular, is likely to spread quickly through a population. The new coronavirus has accumulated mutations of concern faster than many researchers had anticipated. Some variants also contain mutations that may slightly weaken the protection from vaccines. But the immunity produced by vaccines is extremely powerful and should remain effective for years, said Paul Duprex, the Jonas Salk Chair for Vaccine Research at the University of Pittsburgh. “It’s not going to go from being a 94% efficacy to a 32% vaccine efficacy overnight,” he said. The variant identified in Britain differs by about 20 mutations from previous versions of the virus, including at least two mutations that may contribute to its greater contagiousness. As of Jan. 13, it had been detected in 76 cases from 12 states, but the actual numbers are likely to be much higher, Butler said. “CDC expects these numbers to rise in the coming weeks,” he said. The CDC has sequenced about 71,000 samples of the virus, a minuscule fraction of the 23 million people infected in the country to date. But the agency has ramped up its efforts by about sixfold in the past two weeks in light of B.1.1.7 and other variants, said Dr. Gregory Armstrong, who leads molecular surveillance efforts at the agency. State and local public health labs have committed to sequencing about 6,000 samples per week, a target they expect to hit in about three weeks. Agency officials also warned that standard tests for the virus may miss one of the altered genes in the new variant. That should not be an issue for most laboratory-based PCR tests, they said, but some antigen tests may produce “false negatives,” missing cases of infection. “So far, we haven’t found evidence of that, but we’re looking more closely at that,” Butler said. It’s not yet clear what makes the new variants more contagious. They share at least one mutation, called N501Y, that is thought to be involved. One possibility, researchers said, is that the mutation may increase the amount of virus in the nose but not in the lungs — potentially explaining why it is more contagious, but not more deadly. A higher amount of virus in the nose means anyone infected would expel more virus while talking, singing, coughing or even breathing, said Trevor Bedford, an evolutionary biologist at the Fred Hutchinson Cancer Research Center in Seattle. “It makes the same situations that generate spread now — people living in the same household, these sorts of non-ventilated indoor contacts — to be more likely to spread,” he said. This article originally appeared in The New York Times. © 2021 The New York Times Company
VANCOUVER, British Columbia, Jan. 15, 2021 (GLOBE NEWSWIRE) -- American Lithium Corp. (TSXV: LI) (OTCQB: LIACF) (Frankfurt: 5LA1) (“American Lithium” or the “Company”) has been requested by OTC Markets Group Inc. (“OTC Markets”) to comment on recent promotional activity concerning its common shares traded on the OTCQB. On January 12, 2021, OTC Markets sent the Company copies of articles by Promethean Marketing, Inc. (“Promethean”) and Global Profit Systems, LLC (“Global”). Promethean is a third-party marketing and advertising firm which was retained by the Company to provide content distribution and advertising services. While the Company did engage Promethean, it does not have any relationship with Global. The Company was not involved in the preparation of the articles published by Promethean or Global, nor did it have editorial control over the content of the articles, and only became aware of the articles on January 12, 2021, following notification by OTC Markets. The Company does not believe the statements referencing it in the articles were false or misleading. The Company has been advised by OTC Markets that OTC Markets takes the position that aspects of the statements were overly promotional. The Company wishes to caution readers that these statements are speculative in nature. For more complete and specific information regarding the Company, its prospects and the risks associated with those prospects, readers should consult the Company’s website and other reliable sources. The Company does not believe the promotional activities were a factor in the recent increase in trading volume in the Company’s common shares on the OTCQB which occurred on January 12, 2021. Instead, the Company attributes the increase to heightened interest in development-stage lithium projects primarily driven by anticipated demand from the electric vehicle market. After an inquiry of management, none of the Company’s officers, directors, controlling shareholders or third-party service providers have sold or purchased securities of the Company in the past ninety days. In the last twelve months, except for Promethean, the Company has not engaged any parties to provide investor relations, public relations services, marketing or other related services. The Company has not issued any convertible instruments or securities allowing conversion to equity securities at prices constituting a discount to the current market price at the time of issuance. About American Lithium Corp. American Lithium is actively engaged in the acquisition, exploration and development lithium deposits within mining-friendly jurisdictions throughout the Americas. The Company is currently exploring and developing the TLC lithium project located in the highly prospective Esmeralda lithium district in Nevada. TLC is close to infrastructure, 3.5 hours south of the Tesla Gigafactory, and in the same basinal environment as Albemarle’s Silver Peak lithium mine, and several advancing deposits and resources, including Ioneer Ltd.’s (formerly Global Geoscience) Rhyolite Ridge and Cypress Development Corp.’s Clayton Valley Project. For more information, please contact the Company at firstname.lastname@example.org or visit our website at www.americanlithiumcorp.com. On behalf of the Board, American Lithium Corp.Michael Kobler, Chief Executive Officer Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release. Forward-looking statements Statements in this release that are forward-looking information are subject to various risks and uncertainties concerning the specific factors disclosed here. Information provided in this release is necessarily summarized and may not contain all available material information. All such forward-looking information and statements are based on certain assumptions and analyses made by American Lithium management in light of their experience and perception of historical trends, current conditions and expected future developments, as well as other factors management believes are appropriate in the circumstances. These statements, however, are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those projected in the forward-looking information or statements. Important factors that could cause actual results to differ from these forward-looking statements include those described under the heading “Risks Factors” in American Lithium's most recently filed MD&A. The Company does not intend, and expressly disclaims any obligation to, update or revise the forward-looking information contained in this news release, except as required by law. Readers are cautioned not to place undue reliance on forward-looking information or statements.